A functional enhancer of keratin14 is a direct transcriptional target of ΔNp63

Journal of Investigative Dermatology

Volumn 127, Issue 5, 2007, Pages 1175-1186

  Romano, Rose Anne ^a   Birkaya, Barbara ^a   Sinha, Satrajit ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKERATIN 14; DELTA NUCLEAR PROTEIN 63; DNA; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CHROMATIN; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; SKIN EPITHELIUM; TRANSACTIVATION;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; KERATIN-14; KERATINOCYTES; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 34247252481     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700652     Document Type: Article

References (27)

1. Antonini D, Rossi B, Han R, Minichiello A, Di Palma T, Corrado M et al. (2006) An autoregulatory loop directs the tissue-specific expression of p63 through a long-range evolutionarily conserved enhancer. Mol Cell Biol 26:3308-18
2. Barbieri CE, Pietenpol JA (2006) p63 and epithelial biology. Exp Cell Res 312:695-706
3. Byrne C (1997) Regulation of gene expression in developing epidermal epithelia. Bioessays 19:691-8
4. Byrne C, Tainsky M, Fuchs E (1994) Programming gene expression in developing epidermis. Development 120:2369-83
5. Candi E, Rufini A, Terrinoni A, Dinsdale D, Ranalli M, Paradisi A et al. (2006) Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ 13:1037-47
6. Coulombe PA, Omary MB (2002) "Hard" and "soft" principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol 14:110-22
7. Eckert RL, Crish JF, Banks EB, Welter JF (1997) The epidermis: genes on - genes off. J Invest Dermatol 109:501-9
8. Fuchs E, Weber K (1994) Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 63:345-82
9. Kaufman CK, Sinha S, Bolotin D, Fan J, Fuchs E (2002) Dissection of a complex enhancer element: maintenance of keratinocyte specificity but loss of differentiation specificity. Mol Cell Biol 22:4293-308
10. Keyes WM, Wu Y, Vogel H, Guo X, Lowe SW, Mills AA (2005) p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev 19:1986-99
11. Koster MI, Roop DR (2004a) Genetic pathways required for epidermal morphogenesis. Eur J Cell Biol 83:625-9
12. Koster MI, Roop DR (2004b) Transgenic mouse models provide new insights into the role of p63 in epidermal development. Cell Cycle 3: 411-3
13. Koster MI, Kim S, Huang J, Williams T, Roop DR (2006) TAp63alpha induces AP-2gamma as an early event in epidermal morphogenesis. Dev Biol 289:253-61
14. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR (2004) p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 18:126-31
15. Laurikkala J, Mikkola ML, James M, Tummers M, Mills AA, Thesleff I (2006) p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation. Development 133:1553-63
16. Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE (2006) AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells. Oncogene 25:5405-15
17. Lu H, Hesse M, Peters B, Magin TM (2005) Type II keratins precede type I keratins during early embryonic development. Eur J Cell Biol 84:709-18
18. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-13
19. Ortt K, Sinha S (2006) Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53. FEBS Lett 580:4544-50
20. Romano RA, Birkaya B, Sinha S (2006) Defining the regulatory elements in the proximal promoter of DeltaNp63 in keratinocytes: Potential roles for Sp1/Sp3, NF-Y, and p63. J Invest Dermatol 126:1469-79
21. Sinha S, Fuchs E (2001) Identification and dissection of an enhancer controlling epithelial gene expression in skin. Proc Natl Acad Sci USA 98:2455-60
22. Sinha S, Degenstein L, Copenhaver C, Fuchs E (2000) Defining the regulatory factors required for epidermal gene expression. Mol Cell Biol 20:2543-55
23. Stabach PR, Thiyagarajan MM, Woodfield GW, Weigel RJ (2006) AP2alpha alters the transcriptional activity and stability of p53. Oncogene 25:2148-59
24. van Bokhoven H, McKeon F (2002) Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans. Trends Mol Med 8:133-9
25. Yang A, Kaghad M, Caput D, McKeon F (2002) On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18:90-5
26. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V et al. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-16
27. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-8